Real-World Outcome of Psoriasis Subjects in Korea on Adalimumab

Study Identifier
P16-346
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Dermatology - Psoriasis (PsO)
  • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    19 - 99 Years

    Protocol Summary

    The objective of this non-interventional, observational study is to assess the effect of adalimumab on health-related quality of life in participants with Psoriasis in Korea.

    Study Locations

    Location
    Status
    Location
    Hallym University Sacred Heart Hospital /ID# 161697
    Anyang-si, Gyeonggi-do, Gyeonggido, Republic of Korea, 14068
    Status
    Not applicable
    Location
    CHA Bundang Medical center, CHA University /ID# 161696
    Seongnam-si, Gyeonggido, Republic of Korea, 13496
    Status
    Not applicable
    Location
    Ajou University Hospital /ID# 161698
    Suwon, Gyeonggido, Republic of Korea, 16499
    Status
    Not applicable
    Location
    Yonsei University Health System, Severance Hospital /ID# 166300
    Seodaemun-gu, Seoul Teugbyeolsi, Republic of Korea, 03722
    Status
    Not applicable
    Location
    Hanyang University Seoul Hospi /ID# 169553
    Seongdong-gu, Seoul Teugbyeolsi, Republic of Korea, 04763
    Status
    Not applicable
    Location
    Busan National University Hosp /ID# 166299
    Busan, Republic of Korea, 602-739
    Status
    Not applicable
    Showing {first} - {last} of {total} Results